Additionally, RNA-sequencing data showed a higher than expected proportion6 of ASCL1-low tumors (50% vs. 18%; p = 0.01, Fisher’s exact test) in our cohort of relapsed SCLC samples (Fig. 2a). This evidence concerns the gene ASCL1 and small cell lung carcinoma.